{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:05:37Z","timestamp":1770984337961,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"S13","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Herpes Simplex Virus 1 and 2 causes several infections in humans including cold sores and encephalitis. Previous antiviral studies on herpes viruses have focussed on developing nucleoside analogues that can inhibit viral polymerase and terminate the replicating viral DNA. However, these drugs bear an intrinsic non-specificity as they can also inhibit cellular polymerase apart from the viral one. The present study is an attempt to elucidate the action mechanism of naturally occurring withaferin A in inhibiting viral DNA polymerase, thus providing an evidence for its development as a novel anti-herpetic drug.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Withaferin A was found to bind very similarly to that of the previously reported 4-oxo-DHQ inhibitor. Withaferin A was observed binding to the residues Gln 617, Gln 618, Asn 815 and Tyr 818, all of which are crucial to the proper functioning of the polymerase. A comparison of the conformation obtained from docking and the molecular dynamics simulations shows that substantial changes in the binding conformations have occurred. These results indicate that the initial receptor-ligand interaction observed after docking can be limited due to the receptor rigid docking algorithm and that the conformations and interactions observed after simulation runs are more energetically favoured.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We have performed docking and molecular dynamics simulation studies to elucidate the binding mechanism of prospective herbal drug withaferin A onto the structure of DNA polymerase of Herpes simplex virus. Our docking simulations results give high binding affinity of the ligand to the receptor. Long <jats:italic>de novo<\/jats:italic> MD simulations for 10 ns performed allowed us to evaluate the dynamic behaviour of the system studied and corroborate the docking results, as well as identify key residues in the enzyme-inhibitor interactions. The present MD simulations support the hypothesis that withaferin A is a potential ligand to target\/inhibit DNA polymerase of the Herpes simplex virus. Results of these studies will also guide the design of selective inhibitors of DNA POL with high specificity and potent activity in order to strengthen the therapeutic arsenal available today against the dangerous biological warfare agent represented by Herpes Simplex Virus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2105-12-s13-s22","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T05:05:00Z","timestamp":1322802300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A"],"prefix":"10.1186","volume":"12","author":[{"given":"Abhinav","family":"Grover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhuti","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Shandilya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virendra S","family":"Bisaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durai","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,30]]},"reference":[{"key":"4938_CR1","unstructured":"Prevention and control of Herpes virus diseases In Clinical and laboratory diagnosis and chemotherapy. Volume 63. Bulletin of the WHO; 1985:182\u2013185."},{"key":"4938_CR2","first-page":"69","volume-title":"The Human Herpesviruses","author":"RJ Whitley","year":"1993","unstructured":"Whitley RJ, Gnann JWJ: The Human Herpesviruses. In The Human Herpesviruses Edited by: Roizmann B, Whitley RJ, Lopez C. 1993, 69\u2013105."},{"key":"4938_CR3","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/pro.5560061005","volume":"6","author":"K Wild","year":"1997","unstructured":"Wild K, Bohner T, Folkers G, Schulz GE: The structures of thymidine kinase from Herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Science 1997, 6: 2097\u20132106.","journal-title":"Protein Science"},{"key":"4938_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa035144","volume":"350","author":"L Corey","year":"2004","unstructured":"Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM, Paavonen J, Morrow RA, Beutner KR, et al.: Once-daily valacyclovir to reduce the risk of transmission of genital herpes. New England Journal of Medicine 2004, 350: 11\u201320. 10.1056\/NEJMoa035144","journal-title":"New England Journal of Medicine"},{"key":"4938_CR5","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3851\/IMP1467","volume":"14","author":"G Siakallis","year":"2009","unstructured":"Siakallis G, Spandidos DA, Sourvinos G: Herpesviridae and novel inhibitors. Antiviral Therapy 2009, 14: 1051\u20131064.","journal-title":"Antiviral Therapy"},{"key":"4938_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrd1065","volume":"2","author":"DM Coen","year":"2003","unstructured":"Coen DM, Schaffer PA: Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat Rev Drug Discov 2003, 2: 278\u2013288. 10.1038\/nrd1065","journal-title":"Nat Rev Drug Discov"},{"key":"4938_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM198902023200507","volume":"320","author":"PA Chatis","year":"1989","unstructured":"Chatis PA, Miller CH, Schrager LE, Crumpacker CS: Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with Herpes-simplex virus in a patient with Acquired Immunodeficiency Syndrome. New England Journal of Medicine 1989, 320: 297\u2013300. 10.1056\/NEJM198902023200507","journal-title":"New England Journal of Medicine"},{"key":"4938_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJM198902023200505","volume":"320","author":"A Erice","year":"1989","unstructured":"Erice A, Chou S, Biron KK, Stanat SC, Balfour HH, Jordan MC: Progressive disease due to ganciclovir-resistant cytomegalo-virus in immunocompromised patients. New England Journal of Medicine 1989, 320: 289\u2013293. 10.1056\/NEJM198902023200505","journal-title":"New England Journal of Medicine"},{"key":"4938_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM198902023200506","volume":"320","author":"KS Erlich","year":"1989","unstructured":"Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS: Acyclovir-Resistant Herpes-Simplex Virus-Infections in Patients with the Acquired Immunodeficiency Syndrome. New England Journal of Medicine 1989, 320: 293\u2013296. 10.1056\/NEJM198902023200506","journal-title":"New England Journal of Medicine"},{"key":"4938_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.7.1.1","volume":"7","author":"AK Field","year":"1994","unstructured":"Field AK, Biron KK: The end of innocence revisited - resistance of Herpesviruses to antiviral drugs. Clinical Microbiology Reviews 1994, 7: 1\u201313.","journal-title":"Clinical Microbiology Reviews"},{"key":"4938_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","volume":"5","author":"C Gilbert","year":"2002","unstructured":"Gilbert C, Bestman-Smith J, Boivin G: Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 2002, 5: 88\u2013114. 10.1016\/S1368-7646(02)00021-3","journal-title":"Drug Resist Updat"},{"key":"4938_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJM198902023200510","volume":"320","author":"MS Hirsch","year":"1989","unstructured":"Hirsch MS, Schooley RT: Resistance to antiviral drugs: the end of innocence. N Engl J Med 1989, 320: 313\u2013314. 10.1056\/NEJM198902023200510","journal-title":"N Engl J Med"},{"key":"4938_CR13","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1056\/NEJM199312093292405","volume":"329","author":"RG Kost","year":"1993","unstructured":"Kost RG, Hill EL, Tigges M, Straus SE: Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 1993, 329: 1777\u20131782. 10.1056\/NEJM199312093292405","journal-title":"N Engl J Med"},{"key":"4938_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/187152607780090766","volume":"7","author":"A Greco","year":"2007","unstructured":"Greco A, Diaz JJ, Thouvenot D, Morfin F: Novel targets for the development of anti-herpes compounds. Infect Disord Drug Targets 2007, 7: 11\u201318. 10.2174\/187152607780090766","journal-title":"Infect Disord Drug Targets"},{"key":"4938_CR15","doi-asserted-by":"publisher","first-page":"18193","DOI":"10.1074\/jbc.M602414200","volume":"281","author":"S Liu","year":"2006","unstructured":"Liu S, Knafels JD, Chang JS, Waszak GA, Baldwin ET, Deibel MR Jr., Thomsen DR, Homa FL, Wells PA, Tory MC, et al.: Crystal structure of the herpes simplex virus 1 DNA polymerase. Journal of Biological Chemistry 2006, 281: 18193\u201318200. 10.1074\/jbc.M602414200","journal-title":"Journal of Biological Chemistry"},{"key":"4938_CR16","first-page":"359","volume":"103","author":"L Kambizi","year":"2007","unstructured":"Kambizi L, Goosen BM, Taylor MB, Afolayan AJ: Anti-viral effects of aqueous extracts of Aloe ferox and Withania somnifera on herpes simplex virus type 1 in cell culture. South African Journal of Science 2007, 103: 359\u2013360.","journal-title":"South African Journal of Science"},{"key":"4938_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/0255-0857.43580","volume":"26","author":"H Verma","year":"2008","unstructured":"Verma H, Patil PR, Kolhapure RM, Gopalkrishna V: Antiviral activity of the Indian medicinal plant extract, Swertia chirata against herpes simplex viruses: A study by in-vitro and molecular approach. Indian Journal of Medical Microbiology 2008, 26: 322\u2013326. 10.4103\/0255-0857.43561","journal-title":"Indian Journal of Medical Microbiology"},{"key":"4938_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2007.11.037","volume":"262","author":"N Widodo","year":"2008","unstructured":"Widodo N, Takagi Y, Shrestha BG, Ishii T, Kaul SC, Wadhwa R: Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses. Cancer Letters 2008, 262: 37\u201347. 10.1016\/j.canlet.2007.11.037","journal-title":"Cancer Letters"},{"key":"4938_CR19","first-page":"334","volume":"5","author":"L Mishra","year":"2000","unstructured":"Mishra L, Singh B, Dagenias S: Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Alternative Medicine Review 2000, 5: 334\u2013336.","journal-title":"Alternative Medicine Review"},{"key":"4938_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.2042-7158.1998.tb06923.x","volume":"50","author":"S Panda","year":"1998","unstructured":"Panda S, Kar A: Changes in thyroid hormone concentrations after administration of Ashwagandha root extract to adult male mice. Journal of Pharmacy and Pharmacology 1998, 50: 1065\u20131068. 10.1111\/j.2042-7158.1998.tb06923.x","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"4938_CR21","first-page":"488","volume":"46","author":"RD Budhiraja","year":"1987","unstructured":"Budhiraja RD, Sudhir S: Review of Biological-Activity of Withanolides. Journal of Scientific & Industrial Research 1987, 46: 488\u2013491.","journal-title":"Journal of Scientific & Industrial Research"},{"key":"4938_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/(SICI)1099-1573(199809)12:6<451::AID-PTR328>3.0.CO;2-C","volume":"12","author":"S Kulkarni","year":"1998","unstructured":"Kulkarni S, George B, Mathur R: Protective effect of Withania somnifera root extract on electrographic activity in a lithium pilocarpine model of status epilepticus. Phytotherapy Research 1998, 12: 451\u2013453. 10.1002\/(SICI)1099-1573(199809)12:6<451::AID-PTR328>3.0.CO;2-C","journal-title":"Phytotherapy Research"},{"key":"4938_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-8741(00)00309-3","volume":"74","author":"A Bhattacharya","year":"2001","unstructured":"Bhattacharya A, Ghosal S, Bhattacharya SK: Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. Journal of Ethnopharmacology 2001, 74: 1\u20136. 10.1016\/S0378-8741(00)00309-3","journal-title":"Journal of Ethnopharmacology"},{"key":"4938_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0091-3057(03)00110-2","volume":"75","author":"SK Bhattacharya","year":"2003","unstructured":"Bhattacharya SK, Muruganandam AV: Adaptogenic activity of Withania somnifera : an experimental study using a rat model of chronic stress. Pharmacology Biochemistry and Behavior 2003, 75: 547\u2013555. 10.1016\/S0091-3057(03)00110-2","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"4938_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1046\/j.1440-1681.2003.03849.x","volume":"30","author":"G Chaudhary","year":"2003","unstructured":"Chaudhary G, Sharma U, Jagannathan NR, Gupta YK: Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clinical and Experimental Pharmacology and Physiology 2003, 30: 399\u2013404. 10.1046\/j.1440-1681.2003.03849.x","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"4938_CR26","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/molecules14072373","volume":"14","author":"MH Mirjalili","year":"2009","unstructured":"Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazon J: Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules 2009, 14: 2373\u20132393. 10.3390\/molecules14072373","journal-title":"Molecules"},{"key":"4938_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The protein data bank. Nucleic Acids Research 2000, 28: 235\u2013242. 10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Research"},{"issue":"Suppl 1","key":"4938_CR28","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1186\/1471-2105-12-S1-S30","volume":"12","author":"A Grover","year":"2011","unstructured":"Grover A, Shandilya A, Agrawal V, Pratik P, Bhasme D, Bisaria VS, Sundar D: Hsp90\/Cdc37 Chaperone\/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A. BMC Bioinformatics 2011, 12(Suppl 1):S30. 10.1186\/1471-2105-12-S1-S30","journal-title":"BMC Bioinformatics"},{"key":"4938_CR29","unstructured":"NCBI-PubChem Compound database[http:\/\/pubchem.ncbi.nlm.nih.gov\/]"},{"key":"4938_CR30","volume-title":"AMBER 11","author":"DA DT Case","year":"2010","unstructured":"Case DA DT, Cheatham TE, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Wang B, Hayik S, Roitberg A, Seabra G, Kolossv\u00e1ry I, Wong IF, Paesani F, Vanicek J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA: AMBER 11. San Francisco: University of California; 2010."},{"key":"4938_CR31","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GM Morris","year":"1998","unstructured":"Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ: Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 1998, 19: 1639\u20131662. 10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","journal-title":"Journal of Computational Chemistry"},{"key":"4938_CR32","volume-title":"The PyMOL Molecular Graphics System 2002","author":"W DeLano","year":"2002","unstructured":"DeLano W: The PyMOL Molecular Graphics System 2002. San Carlos, CA: DeLano Scientific; 2002."},{"key":"4938_CR33","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1016\/j.febslet.2005.10.031","volume":"579","author":"T Jain","year":"2005","unstructured":"Jain T, Jayaram B: An all atom energy based computational protocol for predicting binding affinities of protein-ligand complexes. Febs Letters 2005, 579: 6659\u20136666. 10.1016\/j.febslet.2005.10.031","journal-title":"Febs Letters"},{"key":"4938_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM: LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995, 8: 127\u2013134. 10.1093\/protein\/8.2.127","journal-title":"Protein Eng"},{"key":"4938_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0166-3542(01)00208-X","volume":"54","author":"RJ Brideau","year":"2002","unstructured":"Brideau RJ, Knechtel ML, Huang A, Vaillancourt VA, Vera EE, Oien NL, Hopkins TA, Wieber JL, Wilkinson KF, Rush BD, et al.: Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses. Antiviral Res 2002, 54: 19\u201328. 10.1016\/S0166-3542(01)00208-X","journal-title":"Antiviral Res"},{"key":"4938_CR36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1128\/AAC.46.3.724-730.2002","volume":"46","author":"NL Oien","year":"2002","unstructured":"Oien NL, Brideau RJ, Hopkins TA, Wieber JL, Knechtel ML, Shelly JA, Anstadt RA, Wells PA, Poorman RA, Huang A, et al.: Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors. Antimicrob Agents Chemother 2002, 46: 724\u2013730. 10.1128\/AAC.46.3.724-730.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"4938_CR37","first-page":"330","volume":"32","author":"M Vajpayee","year":"2000","unstructured":"Vajpayee M, Malhotra N: Antiviral drugs against herpes infection. Indian Journal of Pharmacology 2000, 32: 330\u2013338.","journal-title":"Indian Journal of Pharmacology"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-S13-S22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:37:48Z","timestamp":1630517868000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-12-S13-S22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,30]]},"references-count":37,"journal-issue":{"issue":"S13","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["4938"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-12-s13-s22","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,30]]},"assertion":[{"value":"30 November 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S22"}}